| Financial Year |
March 31 2023 |
| Monetary Funds |
172,966,527.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
468,045,603.73 |
| Advances to Suppliers |
22,346,526.99 |
| Other Receivables |
22,822,181.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
152,743,878.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
181,633,289.09 |
| Total Current Assets |
1,020,808,007.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
124,399,511.65 |
| Fixed Assetes |
207,658,588.09 |
| Under-construction Projects |
2,101,295.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,282,667.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,841,013.96 |
| Deferred Income Tax Assets |
167,383,379.91 |
| Other Non-Current Assets |
1,709,659.12 |
| Sub-Total of Non-Current Assets |
569,784,182.63 |
| Total Assets |
1,590,592,190.07 |
| Short-Term Loans |
379,302,257.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
177,169,599.87 |
| Accounts Received In Advance |
3,036,892.35 |
| Employee Compensation Payable |
6,183,821.58 |
| Taxes Payable |
8,005,966.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,500,179.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
718,386.94 |
| Sub-Total of Current Liabilities |
627,443,157.77 |
| Long-term Loans |
-- |
| Bonds Payable |
238,941,021.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
46,970,116.72 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
296,827,214.10 |
| Total Liabilities |
924,270,371.87 |
| Paid-In Capital(Or Share Stock) |
494,075,180.00 |
| Capital Surplus |
769,572,545.87 |
| Surplus Reserve |
40,459,941.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-688,593,050.15 |
| Minority Stockholder's Interest |
-1,037,089.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
667,358,907.69 |
| Owner's Equity（Stockholder's Equity） |
666,321,818.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,590,592,190.07 |
